Last reviewed · How we verify
NCT03848117
Effects of Mulligan and Cyriax Approach in Patients With Subacute Lateral Epicondylitis.
NA trial testing Cyriax approach i.e. DTF massage and Mill's manipulation in Lateral Epicondylitis in 30 participants. Completed in 15 October 2019.
30 September 2019
Quick facts
| Lead sponsor | Isra University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 March 2019 |
| Primary completion | 30 September 2019 |
| Estimated completion | 15 October 2019 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Cyriax approach i.e. DTF massage and Mill's manipulation
- Mulligan approach i.e. Taping and MWM
Conditions studied
- Lateral Epicondylitis — all drugs for Lateral Epicondylitis →
Sponsor
Isra University
Who can join
Adults 20 to 50, any sex, with Lateral Epicondylitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Lateral epicondylitis (LE) is a pain causing musculoskeletal disease which mainly occurs due to the over exertion or over use of extensors of wrist mainly ECRB and pain is felt at the origin of common extensor tendon. This study was focused to assess the effectiveness of cyriax approach and mulligan approach to improve the functional status of sub acute lateral epicondylitis patients through patient related tennis elbow evaluation form.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03848117
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lateral Epicondylitis
Currently open trials in the same condition.
- NCT07424794 — Mobilization With Movement Verses Cyriax Techniques Among Athletes With Lateral Epicondylitis · NA · recruiting
- NCT07365033 — Eccentric Exercise With Blood Flow Restriction vs Resistance Training for Lateral Epicondylitis · NA · recruiting
- NCT07342426 — High and Low Dose High-intensity Laser Therapy Lateral Epicondylitis · Phase 4 · recruiting
- NCT07410663 — Hyaluronic Acid and Amino Acid Combination Versus Exercise for Chronic Lateral Epicondylitis · active not recruiting
- NCT07314840 — Ultrasonographic Examination of Other Enthesitis Sites in Patients With Lateral Epicondylitis · recruiting
Other Isra University trials
Trials by the same sponsor.
- NCT04427670 — Group Intervention Study for Individuals with Dysarthria Following Stroke and Their Carers in Pakistan · NA · completed
- NCT05104008 — Effectiveness of Lateral Wedge Insole on Knee Osteoarthritis Outcomes in Pakistani Population · NA · completed
- NCT04129190 — Single Non-fasting OGTT Versus Fasting OGTT for Screening of Hyperglycaemia in Pregnancy (HIP) · Phase 2 · unknown
- NCT04536519 — Foot Wear Modification Along With Physical Therapy in Knee Osteoarthritis · NA · completed
- NCT05075473 — SEGMENTAL AND GENERAL STABILIZATION EXERCISES IN CHRONIC LOW BACK PAIN · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03848117 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Isra University
- Last refreshed: 13 November 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03848117.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing